Current Status of PET in the World
The concept of fluorodeoxyglucose positron emission tomography (FDG PET) was conceived in the early 1970s by a number of researchers. In August 1976, the first brain and whole-body images were acquired successfully using the initial type of PET scanner optimized for in vivo imaging with positron-emitting radionuclides in humans (Phelps et al. J Nucl Med 16(3):210–24, 1975). This demonstrated the feasibility of the methodology, but it was still far from clinical study.
KeywordsMedical Care System Private Health Insurance Company Medical Cyclotron Public Insurance System Private Insurance System
- 3.Mansuet M, Grimaldi A, Mangili G, Picchio M, Giovacchini G, Vigano R, Messa C, Fazio F. Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis. Eur J Cancer Care. 2009;18:612–9.CrossRefGoogle Scholar
- 4.van Hooren ACG, Brouwer J, de Bree R, Hoekstra OS, Leemans CR, Uyl-de Groot CA. The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy. Eur Arch Otorhinolaryngol. 2009;266:1441–8.PubMedCrossRefGoogle Scholar
- 5.Sher DJ, Tishler RB, Annino D, Punglia RS. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Ann Oncol. 15 Oct 2009; 21(5):1072–7Google Scholar
- 7.Mansueto M, Grimaldi A, Torbica A, Pepe G, Giovacchini G, Messa C, Fazio F. Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison. Q J Nucl Med Mol Imag. 2007;51(3):224–34. Epub 1 Jun 2007.Google Scholar